Therapeutic potential of ELABELA in alleviating hereditary hypertrophic cardiomyopathy
{{output}}
Introduction: Hereditary hypertrophic cardiomyopathy (HCM) is a common genetic heart disease associated with heart failure and sudden cardiac death. Current therapies are limited, and the myosin inhibitor mavacamten is constraine... ...